Pharma fury as Trump’s team reneges on biologic patent rules in trade talks

A key part of president Donald Trump’s strategy to cut drug prices was to attack global “freeloading” for pharmaceuticals, targeting countries pushing back against pharma companies trying to charge higher US-level prices for their products.